Published in J Urol on July 01, 1999
Variations in reconstruction after radical cystectomy. Cancer (2006) 1.69
Laparoscopic radical cystectomy with prostate capsule sparing. Initial experience. Cent European J Urol (2016) 0.98
Quality of care in bladder cancer: trends in urinary diversion following radical cystectomy. World J Urol (2008) 0.97
Conservative treatment of invasive bladder cancer. Curr Oncol (2009) 0.95
Muscle invasive bladder cancer: from diagnosis to survivorship. Adv Urol (2012) 0.90
Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors. Health Qual Life Outcomes (2013) 0.87
Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results. World J Urol (2011) 0.86
Sexual dysfunction after cystectomy and urinary diversion. Nat Rev Urol (2014) 0.81
Efficacy of bladder-preserving therapy for patients with t3b, t4a, and t4b transitional cell carcinoma of the bladder. Korean J Urol (2010) 0.80
Spatially controlled photothermal heating of bladder tissue through single-walled carbon nanohorns delivered with a fiberoptic microneedle device. Lasers Med Sci (2012) 0.79
Health-related quality of life after cystectomy and urinary diversion for bladder cancer. Adv Urol (2011) 0.79
Bladder-sparing approaches to invasive disease. World J Urol (2006) 0.78
Re: Simplified technique with short and long-term followup of conversion of an ileal conduit to an Indiana pouch. J Urol (2001) 0.75
Long-term urodynamic evaluation of laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer. Oncol Lett (2014) 0.75
Which urinary diversion is best after radical cystectomy? The case for "incontinent" diversion. Can Urol Assoc J (2008) 0.75
Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer. Indian J Urol (2008) 0.75
Determining when to recommend continent urinary diversion. Can Urol Assoc J (2008) 0.75
The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer. Bladder Cancer (2016) 0.75
Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors. Transl Androl Urol (2015) 0.75
The primary health care physician and the cancer patient: tips and strategies for managing sexual health. Transl Androl Urol (2015) 0.75
Participation behavior of bladder cancer survivors in a medical follow-up survey on quality of life in France. Eur J Epidemiol (2004) 0.75
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol (2001) 11.35
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol (2000) 4.96
Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol (1998) 4.35
Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med (1994) 4.34
Stimulation of the human motor cortex through the scalp. Exp Physiol (1991) 3.16
Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer. BJU Int (2003) 2.78
Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst (2000) 2.66
Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer (1971) 2.56
The effect of message framing on breast self-examination attitudes, intentions, and behavior. J Pers Soc Psychol (1987) 2.26
Stenosis of the afferent antireflux valve in the Kock pouch continent urinary diversion: diagnosis and management. J Urol (1994) 2.24
Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst (1995) 2.10
Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J Urol (1999) 2.08
Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst (1998) 2.07
The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2) J Urol (1990) 2.07
A possible role for gap junctions in generation of very fast EEG oscillations preceding the onset of, and perhaps initiating, seizures. Epilepsia (2001) 1.92
Electron microscopy and immunocytochemistry in the assessment of renal biopsy specimens: actual and optimal practice. J Clin Pathol (1996) 1.87
Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy) Ann Oncol (1991) 1.87
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol (1993) 1.85
The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol (1991) 1.81
Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg (1989) 1.71
Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol (1999) 1.67
Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res (1990) 1.67
Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res (1998) 1.65
Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol (1998) 1.59
Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol (1985) 1.55
Diagnostic ultrasound in the evaluation of scrotal masses. J Urol (1977) 1.48
p53 protein and gene alterations in pathological stage C prostate carcinoma. J Urol (1997) 1.45
Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst (1997) 1.45
Uveitis in the elderly--is it easy to identify the masquerade? Br J Ophthalmol (1997) 1.39
Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens. J Urol (1995) 1.38
Measurement of the nucleon strange-antistrange asymmetry at next-to-leading order in QCD from NuTeV Dimuon data. Phys Rev Lett (2007) 1.38
Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol (1996) 1.37
Monitoring in non-traumatic coma. Part I: Invasive intracranial measurements. Arch Dis Child (1988) 1.37
Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol (1998) 1.37
p53 and treatment of bladder cancer. Nature (1997) 1.36
Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res (1998) 1.35
Giant adrenal myelolipoma and testicular interstitial cell tumor in a man with congenital 21-hydroxylase deficiency. Am J Surg Pathol (1979) 1.31
Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder: updated experience in 34 patients. J Urol (1997) 1.30
Management of animal and human bites in the head and neck. Arch Otolaryngol Head Neck Surg (1990) 1.25
Quality of life research in oncology. Past achievements and future priorities. Cancer (1991) 1.23
Estimates of biogenic methane production rates in deep marine sediments at Hydrate Ridge, Cascadia margin. Appl Environ Microbiol (2008) 1.22
Monitoring in non-traumatic coma. Part II: Electroencephalography. Arch Dis Child (1988) 1.20
Adrenal cortical carcinoma associated with venous tumour thrombus extension. Br J Urol (1997) 1.19
Quality of life survey of urinary diversion patients: comparison of ileal conduits versus continent Kock ileal reservoirs. J Urol (1987) 1.18
Positive expectations predict health after heart transplantation. Health Psychol (1995) 1.18
Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management. J Urol (1972) 1.18
Psychosocial correlates of breast cancer and its treatments. Psychol Bull (1980) 1.17
Adjuvant chemotherapy for breast carcinoma: psychosocial implications. Cancer (1979) 1.17
Management of the patient with bladder cancer. Urethral recurrence. Urol Clin North Am (1994) 1.16
Management of adult sarcomas of the bladder and prostate. J Urol (1988) 1.15
Xanthogranulomatous cystitis as a cause of elevated carcinoembryonic antigen mimicking recurrent colorectal cancer. Report of a case. Dis Colon Rectum (1996) 1.15
Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol (1995) 1.13
Role of chromosome 9 in human bladder cancer. Cancer Res (1993) 1.13
Functional properties of rat brain sodium channels expressed in a somatic cell line. Science (1990) 1.12
Urethral recurrence in patients with orthotopic ileal neobladders. J Urol (1996) 1.11
Condylomata acuminata and squamous cell carcinoma. Urology (1977) 1.10
Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease. J Urol (2001) 1.10
Urologic complications of appendicitis. Urology (1975) 1.09
Bilateral emphysematous pyelonephritis: a case report and review of the literature. Urology (1996) 1.09
Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res (1990) 1.09
Sturge-Weber syndrome: cerebral haemodynamics during seizure activity. Dev Med Child Neurol (1999) 1.09
Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer (1998) 1.08
Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol (1984) 1.07
A juvenile animal model to study the growth potential of bowel segments in the urinary tract. J Urol (1990) 1.07
Continent urinary diversion. J Urol (1989) 1.06
The Kock ileal neobladder: updated experience in 295 male patients. J Urol (1996) 1.05
Clinical presentation of coeliac disease in adult gastroenterological practice. Ulster Med J (1985) 1.05
Current perspectives in the management of high-grade invasive bladder cancer. Cancer (1980) 1.04
The surgical management of renal cell carcinoma. J Urol (1972) 1.04
The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol (1993) 1.04
Urinary diversion: the physiological rationale for non-refluxing colonic conduits. Br J Urol (1975) 1.03
An acute scrotum following a laparoscopic appendectomy. Surg Laparosc Endosc (1998) 1.03
Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol (1982) 1.03
Molecular analysis of human bladder cancer. Semin Urol (1990) 1.02
Replacement of the ureter by small intestine: clinical application and results of the ileal ureter in 89 patients. J Urol (1979) 1.00